If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...
Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 9:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback